South Korea Gene Therapy Market Growth, Size, Trends Analysis- By Vector Type, By Method, By Gene Type, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033

South Korea Gene Therapy Market Growth, Size, Trends Analysis- By Vector Type, By Method, By Gene Type, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033

South Korea Gene Therapy Market Introduction and Overview

According to SPER market research, ‘South Korea Gene Therapy Market Size- By Vector Type, By Method, By Gene Type, By Application, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ state that the South Korea Gene Therapy Market is predicted to reach USD 15.33 Million by 2033 with a CAGR of 16.89%.

Gene therapy is a medical procedure that involves changing, adding, or deleting particular genes in a patient’s cells in order to correct genetic problems. This therapeutic approach focuses on the underlying genetic etiology of hereditary disorders, such as cancer or cystic fibrosis. Clinical experiments have yielded encouraging outcomes, and it may be applied to customized care.

The COVID-19 pandemic significantly affected South Korea’s gene therapy industry, upsetting multiple different sectors. Clinical trials were halted, research facilities were few, and research and development (R&D) efforts were significantly postponed. As a result, the pace of ongoing research decreased, patient recruitment was constrained, and advancements in gene therapy were impeded. The supply chain for gene therapy products was also impacted by production problems and raw material shortages caused by travel restrictions and lockdowns.

Scope of the report:

Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Vector Type, By Method, By Gene Type, By Application, By End User

Regions covered

Eastern, Western, Northern, Southern

Companies Covered
CHA Biotech Co., Ltd., CORESTEMCHEMON Inc., Ferring International Center S.A., HELIXMITH Co., Ltd., MEDIPOST Co., Ltd., Novartis Korea Ltd., PHARMICELL Co., Ltd., Rznomics Inc., S-Biomedic, Tego Science, Inc.

South Korea Gene Therapy Market Segmentation:

By Vector Type: Based on the Vector Type, South Korea Gene Therapy Market is segmented as; Viral Vector, Non-Viral Vector.

By Method: Based on the Method, South Korea Gene Therapy Market is segmented as; Ex-Vivo, In-Vivo.

By Gene Type: Based on the Gene Type, South Korea Gene Therapy Market is segmented as; Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors, Others.

By Application: Based on the Application, South Korea Gene Therapy Market is segmented as; Ocological Disorders, Cardiovascular Diseases, Infectious Diseases, Rare Diseases, Neurological Disorders, Other Diseases.